Opioid Abuse Clinical Trial
Official title:
Community Randomized Trial in the Cherokee Nation: Connect and CMCA for Preventing Drug Misuse Among Older Adolescents
Verified date | March 2024 |
Source | Emory University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The target population is students attending high schools in small rural towns in the 14 counties that partially or fully fall within the Cherokee Nation reservation. Following recruitment of 20 school-based clusters, clusters are allocated to either the intervention condition or delayed-intervention control condition using constrained randomization. Constrained randomization helps to ensure balanced cluster sizes as well as similar levels of risk between the intervention and control at baseline. Study participants include all10th grade students enrolled in the participating study high schools and students will be followed into the first year after their expected graduation.
Status | Enrolling by invitation |
Enrollment | 1000 |
Est. completion date | August 2025 |
Est. primary completion date | August 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 17 Years |
Eligibility | Inclusion Criteria: - Tenth grade students enrolled in the participating high schools Exclusion Criteria: - unable to understand written or verbal English Inclusion criteria for high schools: - Counties that partially or fully fall within the Cherokee Nation reservation - Town population of 3,000 or less - Class size between 30 to 100 students Exclusion criteria for high schools: - Metropolitan and micropolitan cores (Rural-Urban Commuting Area codes of 1 and 4) - Existence of a community drug prevention coalition |
Country | Name | City | State |
---|---|---|---|
United States | Cherokee Nation Reservation | Tahlequah | Oklahoma |
Lead Sponsor | Collaborator |
---|---|
Emory University | National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Number of Days of Alcohol Use | The number of days of alcohol use in the past 30 days will be compared between study arms. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Primary | Change in Number of Days of Heavy Alcohol Use | The number of days of heavy alcohol use in the past 30 days will be compared between study arms. Heavy alcohol use is defined as having at least four (among young women) or five (among young men) alcoholic drinks within a couple of hours. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Primary | Change in Number of Days of Marijuana Use | The number of days of marijuana use in the past 30 days will be compared between study arms. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Primary | Change in Number of Days of Opioid Drug Misuse | The number of days of prescription opioid misuse in the past 30 days will be compared between study arms. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Secondary | Change in Social Support | Social support from parents/caregivers, friends, teachers, and community members is assessed with 24 items which are responded to on a 4-point scale where 0 = never and 3 = often. Total scores range from 0 to 72 and higher scores indicate greater support. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Secondary | Change in Perceived Availability of Drugs | Ease or difficulty in accessing alcohol, marijuana, and prescription opioids is assessed with 12 items using a 4-point scale where 0 = very difficult to get and 3 = very easy to get. Total scores range from 0 to 36, with higher scores indicating greater ease of availability. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Secondary | Change in Social Normative Beliefs about Drug Use | Participants will be asked 12 items to assess if they think various social groups disapprove of young people drinking alcohol, using marijuana, and prescription opioid misuse (parents, community adults, peers, self). Responses are given as 0 = don't disapprove, 1 = disapprove, and 2 = strongly disapprove. Total scores range from 0 to 24 with higher scores indicating stronger disapproval. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Secondary | Change in Self-Efficacy | Self-efficacy is assessed with 4 items asking how easy or hard it would be for participants to ask for help or refuse alcohol or drugs. Responses given on a 4-point scale, where 0 = very easy and 3 = very hard. Total scores range from 0 to 12 and lower scores indicate increased self-efficacy. | Baseline (fall of 10th grade) up to spring of 12th grade | |
Secondary | Change in Normative Estimates of Peer Drug Use | Normative estimates of peer drug use (alcohol, marijuana, prescription opioid misuse) are assessed with 3 items asking about how many of their peers in school used drugs in the past year. Possible responses are 0 = none or almost none, 1 = less than half, 2 = about half, 3 = more than half, and 4 = almost all or all. Total scores range from 0 to 12 and higher scores indicate higher normative estimates of peer drug use. | Baseline (fall of 10th grade) up to spring of 12th grade |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05593341 -
Opioid Education in Total Knee Arthroplasty
|
N/A | |
Terminated |
NCT04495374 -
Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy
|
Phase 4 | |
Terminated |
NCT03822962 -
Pain Management Following Sinus Surgery
|
Early Phase 1 | |
Completed |
NCT03936985 -
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
|
||
Active, not recruiting |
NCT01740414 -
Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers
|
Phase 2 | |
Completed |
NCT00499746 -
The Discriminative Effects of Tramadol in Humans
|
Phase 1/Phase 2 | |
Completed |
NCT03684681 -
The Navigator Trial
|
N/A | |
Completed |
NCT04340622 -
Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders
|
N/A | |
Completed |
NCT04018664 -
Oral Abuse Potential Study of Nalbuphine
|
Phase 1 | |
Completed |
NCT00699010 -
Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse
|
Phase 2 | |
Recruiting |
NCT05006079 -
Opioid/Benzodiazepine Polydrug Abuse: Aim 3
|
Phase 2 | |
Completed |
NCT04710069 -
Postoperative Opt-In Narcotic Treatment Study
|
N/A | |
Terminated |
NCT03992079 -
A Multimodal Enhanced Recovery Program in Anorectal Surgery
|
N/A | |
Active, not recruiting |
NCT03570099 -
Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications
|
||
Completed |
NCT02804152 -
Program for Pain & Prescription Opioid Use in Pregnancy
|
N/A | |
Active, not recruiting |
NCT01632982 -
Mobile Psychosocial Interventions for MMT Clients
|
N/A | |
Active, not recruiting |
NCT01136356 -
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05706311 -
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
|
N/A | |
Completed |
NCT03743493 -
PCORnet Opioid Surveillance Study
|
||
Completed |
NCT03143855 -
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
|
Phase 1 |